Skip to main content
. 2017 Jun 28;8(48):83570–83584. doi: 10.18632/oncotarget.18784

Table 2. Metabolites significantly associated with treatment T+E.

ID Name W0 vs. W1 W0 vs. W4 W0 vs. W7 W0 vs. W9 Variation
p-valuea q-value BHb Fold Change p-valuea q-value BHb Fold Change p-valuea q-value BHb Fold Change p-valuea q-value BHb Fold Change
1 Acetate 0.003 0.038 0.73 0.003 0.019 0.71 0.001 0.006 0.66
2 Acetoacetate 0.009 0.042 0.84 0.001 0.009 0.79 0.001 0.023 0.83
3 Acetone 0.0006 0.025 1.27 0.0001 0.002 1.44 0.0001 0.002 1.39
4 Alanine 0.001 0.032 0.83 0.001 0.010 0.80 0.001 0.006 0.81
5 Albumin Lysyl 0.002 0.038 0.83 0.00004 0.002 0.77 0.0006 0.006 0.81
6 Betaine 0.004 0.038 0.82 0.0003 0.005 0.76 0.002 0.012 0.77
7 Choline 0.007 0.040 0.88 0.003 0.016 0.86
8 Citrate 0.002 0.015 0.80
9 Creatine 0.001 0.032 0.83 0.00001 0.001 0.78 0.000001 0.00001 0.76
10 Creatinine 0.00002 0.002 0.86 0.000002 0.0003 0.78 0.000001 0.00001 0.76
11 Fatty acids 0.0006 0.025 1.27 0.010 0.046 1.23 0.001 0.009 1.32 0.003 0.041 1.12
12 Fatty acids (mainly LDL) 0.002 0.015 1.32 0.001 0.006 1.37
13 Fatty acids (mainly VLDL) 0.002 0.015 1.35 0.002 0.012 1.35
14 Glucose 0.002 0.018 0.86 0.0002 0.004 0.82 0.0003 0.013 0.84
15 Glycerol backbone of PGLYs & TAGs 0.003 0.019 1.15 0.001 0.006 1.21 0.0001 0.013 1.20
16 Glycerophosphocholine 0.007 0.040 0.82 0.001 0.006 0.79
17 Histidine 0.004 0.040 0.85 0.0003 0.005 0.82 0.0004 0.006 0.78
18 Isoleucine 0.008 0.035 0.85
19 Lysine 0.001 0.032 0.85 0.001 0.008 0.81 0.0001 0.002 0.79
20 Mannose 0.009 0.036 1.30
21 Methanol 0.002 0.016 0.80 0.001 0.008 0.78
22 Myo-inositol 0.0001 0.003 0.78 0.0001 0.002 0.75
23 NAC 1 0.002 0.011 1.10 0.0003 0.013 1.15
24 Phenylalanine 0.0003 0.019 0.64 0.0003 0.005 0.58 0.001 0.008 0.63 0.002 0.037 0.59
25 Proline 0.001 0.008 0.78
26 Tyrosine 0.002 0.038 0.83 0.00001 0.001 0.74 3 × 10 -8 0.00001 0.67 0.0002 0.012 0.78
27 Valine 0.004 0.038 0.81 0.010 0.046 0.89 0.00002 0.0008 0.70 0.004 0.044 0.86

a p-value without multiple testing correction.

b q-value BH: p-value after Benjamini-Hochberg false discovery rate multiple testing correction. Variation: ↑ corresponds to higher concentration in W1, W4, W7 or W9 serum metabolic profiles than at baseline; ↓ to lower concentration in W1, W4, W7 or W9 serum metabolic profiles than at baseline.